Item 2.02. Results of Operations and Financial Condition.

On May 11, 2021, Syndax Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01.Financial Statements and Exhibits.





(d) Exhibits.



Exhibit
  No.                                  Description


99.1      Press Release, dated May 11, 2021
104       Cover Page Interactive Data File (embedded within the Inline XBRL
        document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses